Search results
Results from the WOW.Com Content Network
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Physicians are perhaps the most important component in sales. They write the prescriptions that determine which drugs will be used by people. Influencing the physician is the key to pharmaceutical sales. Historically, by a large pharmaceutical sales force. A medium-sized pharmaceutical company might have a sales force of 1000 representatives.
In February 2015, AMRI acquired SSCI based in West Lafayette, Indiana. SSCI was founded in 1991, providing comprehensive cGMP solid state chemistry research and analytical services to the pharmaceutical industry. Servicing more than 250 customers a year. [25] [26] In July 2015, the company acquired Gadea Pharmaceutical group for $174 million. [27]
As of April 2020, the company's subsidiaries include: Affivant; Covant; Datavant; Genevant, created to work on RNA-based therapeutics [33]; Hemovant; Immunovant, launched in July 2018 to develop therapies for autoimmune diseases, with lead candidate IMVT-1401 being developed for the treatment of myasthenia gravis, Graves' ophthalmopathy and warm antibody autoimmune hemolytic anemia [34]
AOL latest headlines, entertainment, sports, articles for business, health and world news.
Across the U.S., at least 7,000 pharmacies have closed since 2019. Of those, roughly half were independent drugstores.
In 2019, the company reported US$1,849.9 million in sales. [1] On January 29, 2003, an accumulation of combustible polyethelene powder caused an explosion at a West rubber-manufacturing plant in Kinston, North Carolina. [3] In 2005, West acquired The Tech Group, Scottsdale, Ariz., [4] and Medimop Medical Projects Ltd., Ra’anana, Israel. [5]
By Steven Brill Letter From the Editors Backstage at Johnson & Johnson. On May 20, about 100 stock analysts gathered in the ballroom of the Hyatt Regency Hotel in New Brunswick, New Jersey, to hear good news from top executives at Johnson & Johnson: The company had 10 new drugs in the pipeline that might achieve more than a billion dollars in annual sales.